{"id":"https://openalex.org/W2463060140","doi":null,"title":"[The effect of siRNA-Her2/neu on the drug sensitivity of Her2/neu-overexpressing lung adenocarcinoma cell line].","display_name":"[The effect of siRNA-Her2/neu on the drug sensitivity of Her2/neu-overexpressing lung adenocarcinoma cell line].","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2463060140","mag":"2463060140","pmid":"https://pubmed.ncbi.nlm.nih.gov/16638299"},"language":"en","primary_location":{"id":"pmid:16638299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16638299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases","raw_type":"English Abstract"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107296298","display_name":"Shu-hua Ren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]},{"id":"https://openalex.org/I91656880","display_name":"China Medical University","ror":"https://ror.org/032d4f246","country_code":"CN","type":"education","lineage":["https://openalex.org/I91656880"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shu-hua Ren","raw_affiliation_strings":["Department of Thoracic Surgery, First Affiliated Hospital, China Medical University, Shenyang 110001, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Surgery, First Affiliated Hospital, China Medical University, Shenyang 110001, China","institution_ids":["https://openalex.org/I4210140515","https://openalex.org/I91656880"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lin Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lin Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112701007","display_name":"Jingwei Wang","orcid":"https://orcid.org/0009-0001-7657-6247","observed_orcids":["https://orcid.org/0009-0001-7657-6247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing-wei Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047847539","display_name":"Hai-mei Tian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hai-mei Tian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102018980","display_name":"Ping Q\u00fc","orcid":"https://orcid.org/0009-0005-6442-6558","observed_orcids":["https://orcid.org/0009-0005-6442-6558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ping Q\u00fc","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100711220","display_name":"Wei Zhang","orcid":"https://orcid.org/0000-0003-4423-1030","observed_orcids":["https://orcid.org/0000-0003-4423-1030"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34754155,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"1","first_page":"35","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.08160000294446945,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.014299999922513962,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.9010000228881836},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.699999988079071},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/calu-3-cells","display_name":"Calu-3 cells","score":0.9200000166893005},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.7680000066757202},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.8539999723434448},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6420000195503235},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9369999766349792},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5389999747276306},{"id":"https://openalex.org/keywords/targeted-gene-therapy","display_name":"targeted gene therapy","score":0.5070000290870667},{"id":"https://openalex.org/keywords/sirna-off-target-effects","display_name":"siRNA off-target effects","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C49923114","wikidata":"https://www.wikidata.org/wiki/Q17139621","display_name":"Lipofectamine","level":5,"score":0.8075519800186157},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.704018235206604},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6241716146469116},{"id":"https://openalex.org/C2776872082","wikidata":"https://www.wikidata.org/wiki/Q181874","display_name":"HER2/neu","level":4,"score":0.5958499312400818},{"id":"https://openalex.org/C22615655","wikidata":"https://www.wikidata.org/wiki/Q203221","display_name":"Small interfering RNA","level":4,"score":0.5875338315963745},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5678455829620361},{"id":"https://openalex.org/C88634738","wikidata":"https://www.wikidata.org/wiki/Q24769543","display_name":"Annexin","level":3,"score":0.5615121126174927},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.5049403309822083},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4969194233417511},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4871253967285156},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.46491342782974243},{"id":"https://openalex.org/C2779637612","wikidata":"https://www.wikidata.org/wiki/Q2354337","display_name":"Phosphatidylserine","level":4,"score":0.437296599149704},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.43420588970184326},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.4259500801563263},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42404115200042725},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.41389283537864685},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3626127541065216},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3276769518852234},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31287622451782227},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.2679639458656311},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21448954939842224},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1808241605758667},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.16446298360824585},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14224141836166382},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.09374916553497314},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08204969763755798},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.061193645000457764},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.0},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018734","descriptor_name":"Genes, erbB-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16638299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16638299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases","raw_type":"English Abstract"},{"id":"mag:2463060140","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16638299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7100838638","https://openalex.org/W1989513884","https://openalex.org/W2090749547","https://openalex.org/W7099525466","https://openalex.org/W2373398966","https://openalex.org/W237845317","https://openalex.org/W2388326680","https://openalex.org/W1994296373","https://openalex.org/W2064974685","https://openalex.org/W2217204039"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"explore":[2],"the":[3,12,101,116,120,124,129,162,175,180,191,220,223,227,252,265,269,274,286],"effect":[4,186],"of":[5,15,25,69,80,161,179,194,255,284,288],"synthesized":[6],"siRNA":[7,39,44,118,131,165,199,229,239,267],"targeting":[8,200],"Her2/neu":[9,43,65,108,117,167,181,201,238],"oncogene":[10],"on":[11,187],"drug":[13,102],"sensitivity":[14],"Her2/neu-overexpressing":[16],"lung":[17],"adenocarcinoma":[18,53],"cell":[19,54,176],"line.":[20],"METHODS:":[21],"The":[22,78,107,248],"experiments":[23],"consisted":[24],"four":[26],"groups":[27,244],"including":[28],"an":[29,33,37],"untreated":[30,121,221,275],"control":[31,122,276],"group,":[32,36,40,119,123,268],"empty":[34,125,224,270],"vector":[35,126,225,271],"unrelated":[38,130,228,266],"and":[41,64,67,110,128,215,226,241],"a":[42,234],"group.":[45,277],"Every":[46],"experiment":[47],"was":[48,57,86,97,202,208,233,260,282],"repeated":[49],"five":[50],"times.":[51],"Lung":[52],"line":[55],"Calu-3":[56,169,289],"transfected":[58,81],"with":[59,198,258,264],"siRNAs":[60],"formulated":[61],"LipofectAMINE":[62],"2000,":[63],"protein":[66,109],"P-gp":[68,111,188],"each":[70],"group":[71,127,132,240,272],"were":[72,133],"determined":[73],"by":[74,88],"flow":[75],"cytometry":[76],"(FCM).":[77],"chemosensitivity":[79,287],"cells":[82,170,290],"to":[83,99,291],"cisplatin":[84],"(DDP)":[85],"measured":[87],"MTT.":[89],"Cell":[90],"apoptosis":[91,104,253],"detection":[92],"kit":[93],"(Annexin":[94],"V":[95],"method)":[96],"used":[98],"examine":[100],"induced":[103],"rate.":[105],"RESULTS:":[106],"positive":[112,168],"expression":[113,178],"rate":[114,193,254],"in":[115,171,196,219],"[(25.04":[134],"+/-":[135,138,141,144,147,150,154,157,204,210,213,217],"1.56)%,":[136],"(4.24":[137],"1.01)%],":[139],"[(98.24":[140],"2.23)%,":[142],"(5.11":[143],"2.98)%],":[145],"[(95.67":[146],"1.98)%,":[148],"(6.98":[149],"2.47)%]":[151],"or":[152,273],"[(94.79":[153],"0.87)%,":[155],"(5.59":[156],"3.66)%],":[158],"respectively.":[159,231],"Introduction":[160],"sequence":[163],"specific":[164,280],"into":[166],"vitro":[172],"greatly":[173],"reduced":[174],"surface":[177],"protein,":[182],"but":[183,206],"had":[184],"no":[185],"level.":[189],"Consequently":[190],"inhibitory":[192],"DDP":[195,256],"combination":[197],"(67.1":[203],"2.3)%,":[205],"it":[207],"(48.1":[209],"3.5)%,":[211],"(46.3":[212],"5.9)%":[214],"(50.2":[216],"2.9)%":[218],"control,":[222],"groups,":[230],"There":[232],"significant":[235],"difference":[236],"between":[237],"other":[242],"three":[243],"(P":[245],"<":[246],"0.01).":[247],"FCM":[249],"results":[250],"showed":[251],"combined":[257],"siRNA-Her2/neu":[259,281],"elevated":[261],"as":[262],"compared":[263],"CONCLUSION:":[278],"Sequence":[279],"capable":[283],"enhancing":[285],"cisplatin.":[292]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-07-22T00:00:00"}